We found here that LINC02159 upregulated YAP1 expression through ALYREF, which activated both Hippo and Wnt/β-catenin pathways, further proving the importance of YAP1 regulation by lncRNA in NSCLC progression. Here, ALYREF is linked to non-small cell lung carcinoma.